These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27975248)

  • 1. Assays for the Screening and Characterization of Tau Aggregation Inhibitors.
    Rickard JE; Horsley D; Wischik CM; Harrington CR
    Methods Mol Biol; 2017; 1523():129-140. PubMed ID: 27975248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays for the Screening and Characterization of Tau Aggregation Inhibitors.
    Horsley D; Rickard JE; Vorley T; Leeper MF; Wischik CM; Harrington CR
    Methods Mol Biol; 2024; 2754():93-104. PubMed ID: 38512662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.
    Harrington CR; Storey JM; Clunas S; Harrington KA; Horsley D; Ishaq A; Kemp SJ; Larch CP; Marshall C; Nicoll SL; Rickard JE; Simpson M; Sinclair JP; Storey LJ; Wischik CM
    J Biol Chem; 2015 Apr; 290(17):10862-75. PubMed ID: 25759392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.
    Wischik CM; Schelter BO; Wischik DJ; Storey JMD; Harrington CR
    J Alzheimers Dis; 2018; 62(3):1287-1303. PubMed ID: 29226873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and Quantification Methods for Fibrillar Products of In Vitro Tau Aggregation Assays.
    Nanavaty N; Lin L; Hinckley SH; Kuret J
    Methods Mol Biol; 2017; 1523():101-111. PubMed ID: 27975246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
    Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
    ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    Jouanne M; Rault S; Voisin-Chiret AS
    Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
    Okuda M; Hijikuro I; Fujita Y; Wu X; Nakayama S; Sakata Y; Noguchi Y; Ogo M; Akasofu S; Ito Y; Soeda Y; Tsuchiya N; Tanaka N; Takahashi T; Sugimoto H
    PLoS One; 2015; 10(2):e0117511. PubMed ID: 25659102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of serine 305 in tau inhibits aggregation.
    Strang KH; Sorrentino ZA; Riffe CJ; Gorion KM; Vijayaraghavan N; Golde TE; Giasson BI
    Neurosci Lett; 2019 Jan; 692():187-192. PubMed ID: 30423399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells.
    Hu JY; Zhang DL; Liu XL; Li XS; Cheng XQ; Chen J; Du HN; Liang Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):414-427. PubMed ID: 27890528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular factors modulating the mechanism of tau protein aggregation.
    Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
    Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of tau aggregation inhibitors for Alzheimer's disease.
    Bulic B; Pickhardt M; Schmidt B; Mandelkow EM; Waldmann H; Mandelkow E
    Angew Chem Int Ed Engl; 2009; 48(10):1740-52. PubMed ID: 19189357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.
    Rane JS; Bhaumik P; Panda D
    J Alzheimers Dis; 2017; 60(3):999-1014. PubMed ID: 28984591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.
    Ayyadevara S; Balasubramaniam M; Parcon PA; Barger SW; Griffin WS; Alla R; Tackett AJ; Mackintosh SG; Petricoin E; Zhou W; Shmookler Reis RJ
    Aging Cell; 2016 Oct; 15(5):924-39. PubMed ID: 27448508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
    Gaudreault R; Hervé V; van de Ven TGM; Mousseau N; Ramassamy C
    J Alzheimers Dis; 2021; 81(1):33-55. PubMed ID: 33749653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.
    Sonawane SK; Uversky VN; Chinnathambi S
    Cell Commun Signal; 2021 Feb; 19(1):16. PubMed ID: 33579328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol Inhibits Tau Aggregation In Vitro.
    Alali S; Riazi G; Ashrafi-Kooshk MR; Meknatkhah S; Ahmadian S; Hooshyari Ardakani M; Hosseinkhani B
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
    Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
    Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
    Repalli J; Meruelo D
    Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.